Accretion Nutraveda Limited is entering the public markets through SME IPO with an issue size of ₹24.77 crore. The issue consists of a fresh issue of equity shares. The shares are proposed to be listed on BSE & SME.
The IPO subscription window opens on January 28, 2026 and will remain open until January 30, 2026. The company plans to list its shares on February 4, 2026. Being an SME IPO, the issue may appeal to investors familiar with lower liquidity listings.
Accretion Nutraveda Limited IPO Timeline
IPO Quick Facts
This section covers the main IPO details of Accretion Nutraveda Limited that investors generally review before applying.
IPO Details at a Glance
| Company Name | Accretion Nutraveda Limited |
|---|---|
| IPO Segment | SME |
| Sale Type | Fresh Issue |
| Issue Type | Bookbuilding IPO |
| Price | ₹129 Per Share |
| Lot Size | 1,000 Shares |
| Face Value | ₹10 Per Share |
| Exchange | BSE & SME |
Investor Category & Share Allocation
| Investor Category | Shares Offered | % of Issue |
|---|---|---|
| Market Maker | 96,000 | 5.00% |
| Qualified Institutional Buyers (QIB) | 908,000 | 47.29% |
| — Anchor Investor | 544,000 | 28.33% |
| — QIB (Ex Anchor) | 364,000 | 18.96% |
| NII (HNI) | 276,000 | 14.37% |
| — bNII > ₹10L | 184,000 | 9.58% |
| — sNII < ₹10L | 92,000 | 4.79% |
| Retail | 640,000 | 33.33% |
| Total Shares Offered | 1,920,000 | 100.00% |
Accretion Nutraveda Limited IPO Important Dates
The following table highlights the key dates for the Accretion Nutraveda Limited IPO, covering the subscription period and the expected listing timeline.
| IPO Opening Date | 28 Jan 2026 |
|---|---|
| IPO Closing Date | 30 Jan 2026 |
| Allotment Finalization | 02 Feb 2026 |
| Initiation of Refunds | 03 Feb 2026 |
| Credit of Shares | 03 Feb 2026 |
| IPO Listing Date | 04 Feb 2026 |
Accretion Nutraveda Limited IPO Size & Structure
| Total IPO Size | ₹24.77 Crore |
|---|---|
| Fresh Issue | ₹24.77 Crore |
Accretion Nutraveda IPO Lot Size & Minimum Investment
The table below shows the lot size and investment amount for the Accretion Nutraveda IPO, which is a fixed price IPO priced at ₹129 per share.
Investors can apply for the IPO with a minimum of 1000 shares. Applications must be made in multiples of 1000 shares.
- Retail investors can apply from 2 lot to 2 lots.
- Small HNI (SHNI) investors must apply for at least 3 lots.
- Big HNI (BHNI) investors need to apply for a minimum of 8 lots.
This information helps investors understand the minimum investment required before applying for the IPO.
Note: Retail investors generally apply at the cut-off price, which is ₹129 per share.
| Category | Lots | Shares | Price | Amount |
|---|---|---|---|---|
| Retail (Min) | 2 | 2,000 | ₹129 | ₹258,000 |
| Retail (Max) | 2 | 2,000 | ₹129 | ₹258,000 |
| S-HNI (Min) | 3 | 3,000 | ₹129 | ₹387,000 |
| S-HNI (Max) | 7 | 7,000 | ₹129 | ₹903,000 |
| B-HNI | 8 | 8,000 | ₹129 | ₹1,032,000 |
Accretion Nutraveda Limited IPO GMP (Grey Market Premium)
The latest Accretion Nutraveda Limited IPO GMP (Grey Market Premium), along with Kostak rates and Subject to Sauda rates, helps in understanding market sentiment. The current Accretion Nutraveda Limited IPO GMP is ₹16 (12.40%), compared to the IPO issue price of ₹129. Based on the current GMP, the expected listing price is around ₹145. The Lowest GMP was ₹0 on 30 Jan 2026, while the highest GMP reached ₹16 on 04 Feb 2026.
Accretion Nutraveda Limited IPO was listed on the stock exchange on 04 Feb 2026. The IPO was subscribed 1.77 times. The first reported GMP was ₹0 (0%), while the latest recorded GMP stood at ₹16 (12.4%).Listing Details:
- Issue Price: ₹129 per share.
- Listing Price: ₹191.00 (approx. 48.06% gain)
- Listing Date: 04 Feb 2026
Accretion Nutraveda Limited IPO GMP Today - Trend Analysis
| Date | Issue Price (₹) | GMP Price (₹) | Estimated Gain (%) | Estimated Price (₹) | Estimated Profit (₹) |
|---|---|---|---|---|---|
| 04 Feb 2026 | ₹129 | ₹16 | 12.4% | ₹145 | ₹32,000 |
| 03 Feb 2026 | ₹129 | ▲ ₹16 | ▲ 12.4% | ₹145 | ₹32,000 |
| 02 Feb 2026 | ₹129 | ▲ ₹6 | ▲ 4.65% | ₹135 | ₹12,000 |
| 01 Feb 2026 | ₹129 | ₹4 | 3.1% | ₹133 | ₹8,000 |
| 31 Jan 2026 | ₹129 | ▲ ₹4 | ▲ 3.1% | ₹133 | ₹8,000 |
| 30 Jan 2026 | ₹129 | ₹0 | 0% | ₹129 | ₹0 |
| 29 Jan 2026 | ₹129 | ₹0 | 0% | ₹129 | ₹0 |
| 28 Jan 2026 | ₹129 | ₹0 | 0% | ₹129 | ₹0 |
| 27 Jan 2026 | ₹129 | ₹0 | 0% | ₹129 | ₹0 |
| 26 Jan 2026 | ₹129 | ₹0 | 0% | ₹129 | ₹0 |
| 24 Jan 2026 | ₹129 | ₹0 | 0% | ₹129 | ₹0 |
| 23 Jan 2026 | ₹129 | ₹0 | 0% | ₹129 | ₹0 |
| 22 Jan 2026 | ₹129 | ₹0 | 0% | ₹129 | ₹0 |
| 21 Jan 2026 | ₹129 | ₹0 | 0% | ₹129 | ₹0 |
| 20 Jan 2026 | ₹129 | ₹0 | 0% | ₹129 | ₹0 |
Accretion Nutraveda Limited IPO GMP gives retail and institutional investors an idea about short-term market expectations. Although grey market premium does not guarantee listing performance, it is still commonly referred to while analysing IPOs. Investors are advised to look at Accretion Nutraveda Limited fundamentals along with IPO GMP data before making any investment decision.
GMP Disclaimer: GMP (Grey Market Premium) prices are unofficial and only reflect market sentiment. We neither participate in grey-market trading nor encourage it. Investors are strongly advised to review the company’s fundamentals, risks, and official documents before considering an investment in the Accretion Nutraveda Limited IPO.
Accretion Nutraveda Limited IPO Subscription Status
Accretion Nutraveda Limited IPO was subscribed 1.77 times overall on the final day of bidding (as of 30 Jan 2026).The subscription opened on 28 Jan 2026. The Retail portion was subscribed 2.19 times, while QIB and NII categories were subscribed 1.01 times and 1.8 times respectively.
Subscription by Category (QIB, NII, Retail, Employee)
Daily Subscription Trend (Day-wise):
| Date | QIB | NII | Retail | Employee | Total |
|---|---|---|---|---|---|
| 28 Jan 2026 | — | 0.34x | 0.21x | — | 0.19x |
| 29 Jan 2026 | 0.99x | 0.74x | 0.43x | — | 0.66x |
| 30 Jan 2026 | 1.01x | 1.8x | 2.19x | — | 1.77x |
The Accretion Nutraveda Limited IPO opened with a steady response on Day-1, supported mainly by early interest from NII investors.
On Day-2, the Accretion Nutraveda Limited IPO witnessed better demand, led by increased participation from QIB, followed by NII investors.
By the end of the bidding period, the IPO was subscribed 1.77x overall, reflecting strong demand from key investor categories, led by Retail, followed by NII and QIB investors. Overall subscription for the Accretion Nutraveda Limited IPO increased from 0.19x on Day-1 to 1.77x by the final day.
Accretion Nutraveda Limited IPO Final Subscription
| Category | Subscription |
|---|---|
| Qualified Institutional Buyers (QIB) | 1.01x |
| Non-Institutional Investors (NII) | 1.8x |
| Retail Investors | 2.19x |
| Total | 1.77x |
Accretion Nutraveda Limited IPO Allotment Status
The Accretion Nutraveda Limited IPO allotment status was released on 02 Feb 2026. Investors who applied for the IPO can now check their Accretion Nutraveda Limited allotment status online through the official registrar website and NSE / BSE portal.
- 🗓 Allotment Date: 02 Feb 2026
- 📈 Listing Date: 04 Feb 2026
How to Check Accretion Nutraveda Limited IPO Allotment Status Online?
Investors can check the Accretion Nutraveda Limited IPO allotment status online through KFin Technologies Limited and BSE websites. All platforms provide easy access to the IPO allotment details.
Just follow the below mentioned steps to check your allotment status.You can also visit
KFin Technologies
to know more about the IPO registrar.
Check on KFin Technologies Limited (IPO Registrar)
- Visit → KFin Technologies Limited
- Select Accretion Nutraveda Limited
- Enter Application No / Demat Account / PAN details
- Click Submit to view allotment status
Check on BSE (Bombay Stock Exchange) Website
- Visit → BSE Website.
- Select Issue Type: Equity.
- Choose Accretion Nutraveda Limited IPO.
- Enter your PAN or Application Number.
- Click on Search button.
The Bombay Stock Exchange (BSE) also allows investors to check the Accretion Nutraveda Limited IPO allotment status online.
Note: Allotment status is published only on the official registrar websites. We do not collect investor data or provide allotment verification directly.
How to Apply for Accretion Nutraveda Limited IPO?
Login to Your Trading App
Open your trading app such as Angel One, Zerodha, Upstox, Groww or any brokerage app.
Go to the IPO Section
Navigate to the IPO section in the app, search for the IPO, and enter your bid details.
Enter Your UPI ID
Provide your UPI ID that is linked to your bank account for payment authentication.
Approve the Mandate
Open your UPI app and approve the payment mandate to block the required amount.
Application Confirmation
Application submitted successfully, the funds will remain blocked until allotment is finalized.
Accretion Nutraveda Limited debuted at ₹191, listing at a premium of +₹62 (+48.06%). The stock closed at ₹191.2. Investors earned a profit of +₹62,200 per lot.
📌 IPO Issue Price and Lot Size
The IPO of Accretion Nutraveda Limited was offered in the price band of ₹129 to ₹129 per share.
- The final issue price was fixed at ₹129.
- One lot consisted of 1000 shares.
- Minimum investment: ₹129 × 1000 = ₹129,000
- Investment after Day-1: ₹191.2 × 1000 = ₹191,200
- By the end of the listing session, investors made a profit of +₹62,200 per lot.
📌 IPO Subscription Analysis
| Day | QIB | NNI | Retail | Total |
|---|---|---|---|---|
| Day 1 | 0x | 0.34x | 0.21x | 0.19x |
| Day 2 | 0.99x | 0.74x | 0.43x | 0.66x |
| Day 3 | 1.01x | 1.8x | 2.19x | 1.77x |
📌 Final Assessment
Overall Outcome: Outstanding IPO
- Subscription Phase: Weak investor participation
- Listing Phase: Bumper listing performance
- Investor Experience: Strong short-term gains for investors
About Accretion Nutraveda Limited
Incorporated in 2021, Accretion Nutraveda is engaged in the manufacturing of Ayurvedic and Nutraceutical products in various dosage forms.
IPO Financial Summary
- Total Assets changed by 134.05% in FY 2024-2025.
- Total Revenue changed by 208.85% in FY 2024-2025.
- Profit After Tax changed by 218.29% in FY 2024-2025.
- Reserves & Surplus changed by 575% in FY 2024-2025.
- Total Borrowings changed by 77.88% in FY 2024-2025.
| Metric | 2025-09-30 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Total Assets (₹ Cr) | 16.35 | 10.86 | 4.64 | 4.06 |
| Total Revenue (₹ Cr) | 14.07 | 16.06 | 5.20 | 3.07 |
| Profit After Tax (₹ Cr) | 2.33 | 2.61 | 0.82 | 0.28 |
| Reserves & Surplus (₹ Cr) | 2.95 | 4.86 | 0.72 | -0.10 |
| Total Borrowings (₹ Cr) | 4.43 | 3.86 | 2.17 | 1.97 |
Accretion Nutraveda Peer Comparison
The following table helps investors compare Accretion Nutraveda IPO with its listed peers based on important financial and valuation parameters as of September 30, 2025.
| # | Company Name | EPS (₹) | P/E (x) | NAV (₹) | P/BV (x) | RoNW (%) |
|---|---|---|---|---|---|---|
| 1 | Accretion Nutraveda | 4.73 | - | 16.74 | - | 56.50 |
| 2 | Walpar Nutritions | 1.06 | 3.30 | 17.05 | 2.65 | 6.24 |
| 3 | Influx Healthtech | 4.81 | 46.99 | 38.98 | 5.95 | 11.10 |
Utilisation of Proceeds
The Company proposes to utilise the net IPO proceeds of approximately ₹21.44 crore towards the following objectives:
| # | Purpose | Amount (₹ Cr) | % of Total |
|---|---|---|---|
| 1 | Purchase of Machineries for Automation in existing Manufacturing unit | 4.22 | 19.68% |
| 2 | Purchase of Machineries for New Manufacturing Setup | 8.03 | 37.45% |
| 3 | Funding working capital requirements of our company | 5.50 | 25.65% |
| 4 | General corporate purposes | 3.69 | 17.21% |
| Total | 21.44 | 100% | |
Accretion Nutraveda IPO Promoter Holding
| Promoter(s) | Mr. Mayur Popatlal Sojitra, Mr. Ankurkumar Shantilal Patel, Mr. Paraskumar Vinubhai Parmar, Mr. Hardik Mukundbhai Prajapati, Mr. Harshad Nanubhai Rathod & Mr. Vivek Ashok Kumar Patel |
|---|---|
| Pre-Issue Holding | 100% |
| Post-Issue Holding | 73.48% |
Accretion Nutraveda Limited IPO FAQs
The Accretion Nutraveda Limited IPO is a SME Bookbuilding IPO with a total issue size of ₹24.77 crore. The issue consists of a fresh issue of ₹24.77 crore.
The IPO will open for subscription on Wed, 28 Jan 2026 and will close on Fri, 30 Jan 2026.
The shares are being offered at a fixed issue price of ₹129 per equity share.
Investors can apply for the IPO with a minimum lot size of 1,000 shares.
At the upper price band, the minimum investment required for one lot is approximately ₹258,000.
The shares of Accretion Nutraveda Limited are expected to be listed on BSE & SME on Wed, 04 Feb 2026.
The Grey Market Premium (GMP) of Accretion Nutraveda Limited IPO is ₹16.
The expected listing price of Accretion Nutraveda Limited IPO is around ₹145 based on current GMP. This indicates a potential return of approximately 12.40% , with an estimated profit of ₹16,000 per lot, subject to market conditions.
The Accretion Nutraveda Limited IPO was subscribed 1.77 times on the final day of subscription.
The retail portion is subscribed 2.19 times as of 30 Jan 2026.
The QIB portion is subscribed 1.01 times and the NII portion is subscribed 1.8 times .
The IPO registrar of Accretion Nutraveda Limited is KFin Technologies Limited. KFin is responsible for processing IPO applications, finalizing allotment, crediting shares, and initiating refunds.
The allotment date is expected on Mon, 02 Feb 2026.
Allotment status is generally updated in the evening (6 PM – 10 PM) on Mon, 02 Feb 2026 on the registrar or exchange website.
Shares are expected to be credited by Tue, 03 Feb 2026.
Refunds for unsuccessful applicants will be initiated on Tue, 03 Feb 2026.
Investors can check refund status via:
- UPI mandate / bank account (NACH, NEFT, RTGS)
- ASBA bank portal
Accretion Nutraveda Limited IPO is listed on BSE.
The current share price of Accretion Nutraveda Limited is ₹188.20. The stock opened at ₹195.00, hit a high of ₹196.00 and a low of ₹182.70.
Accretion Nutraveda Limited share price has decreased by ₹9.40 (4.76%) compared to the previous close. The stock has declined 1.47% from its listing price of ₹191.00 on BSE.
Disclaimer: The content published on this website is for informational and educational purposes only and must not be treated as financial, trading or investment advice. Share Market related articles, IPO details, GMP values, subscription data, listing estimates, allotment status and related information reflect market sentiment and public data and may be inaccurate or outdated. Nothing on this website constitutes an offer or recommendation to buy or sell any securities. We are not SEBI registered financial advisors. Investors must consult a qualified SEBI registered financial advisor before making any investment decisions. Any investment made based on the information provided here is entirely at the reader’s own risk. The author and the team at TheFinancialTalks.com shall not be responsible or liable for any financial loss. Investors must conduct thorough due diligence and seek professional financial advice before making any investment decisions.